M&A - Beck Peter

Form Type: SCHEDULE 13D/A

Filing Date: 2025-06-17

Corporate Action: Merger

Type: Update

Accession Number: 000095017025087591

Filing Summary: This Amendment No. 4 amends the previous Schedule 13D originally filed on September 7, 2021, highlighting changes including a holding company reorganization implemented by Rocket Lab USA, Inc. on May 23, 2025. This reorganization involved a merger wherein Rocket Lab Merger Sub, Inc. merged into Rocket Lab USA, allowing RL USA to continue as a wholly owned subsidiary of Rocket Lab Corporation. The document details the conversion of shares of common and preferred stock as a result of the merger, with the Company now being the successor issuer. Additionally, on June 13, 2025, a Rule 10b5-1 plan for stock sales was initiated by the Trust for diversification and financial planning purposes. On June 17, 2025, the Trust converted 5,000,000 shares of Preferred Stock to Common Stock for planned sales. It is noted that no other transactions in Company securities were executed by the Reporting Persons in the preceding 60 days, with the details of Mr. Beck's holdings of Common Stock and restricted stock units also outlined.

Form Type: SCHEDULE 13D/A

Filing Date: 2025-01-10

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025004309

Filing Summary: On January 7, 2025, Rocket Lab USA, Inc. completed a Preferred Stock Exchange, wherein 50,951,250 shares of Common Stock held by the Equatorial Trust were exchanged for 50,951,250 shares of Series A Convertible Participating Preferred Stock. The closing required the company to file a Certificate of Designation of the Preferred Stock with the Secretary of State. This document serves as Amendment No. 3 to Schedule 13D, originally filed on September 7, 2021, incorporating previous amendments. The Reporting Persons confirm no additional transactions in Common Stock have occurred in the past 60 days, aside from the exchange noted herein.